Walleye Trading’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,700
Closed -$79K 4732
2024
Q4
$79K Buy
+1,700
New +$76.8K ﹤0.01% 3651
2023
Q4
Sell
-11,500
Closed -$233K 5516
2023
Q3
$233K Sell
11,500
-13,600
-54% -$299K ﹤0.01% 3500
2023
Q2
$514K Buy
25,100
+19,500
+348% +$292K ﹤0.01% 2725
2023
Q1
$84.4K Buy
+5,600
New +$124K ﹤0.01% 3917
2022
Q4
Sell
-4,500
Closed -$159K 5427
2022
Q3
$159K Sell
4,500
-100
-2% -$4.25K ﹤0.01% 3841
2022
Q2
$161K Buy
4,600
+2,200
+92% +$77.9K ﹤0.01% 3852
2022
Q1
$119K Sell
2,400
-6,600
-73% -$366K ﹤0.01% 4147
2021
Q4
$697K Buy
+9,000
New +$924K ﹤0.01% 2608
2021
Q2
Sell
-100
Closed -$12K 5564
2021
Q1
$12K Buy
+100
New +$15.2K ﹤0.01% 4622

Other funds holding TWST

Walleye Trading's TWST Position: Q2 2023 in Review

Walleye Trading sold out of Twist Bioscience (TWST) in Q2 2023, closing a stake of 2,462 shares — an estimated $36.9K sold.

Walleye Trading first reported a position in TWST in Q4 2020 and held it in 7 quarters. The position peaked at $212K in Q4 2020. 193 funds tracked by Wall St. Rank hold TWST as of Q2 2023.

  • Walleye Trading reported no remaining Twist Bioscience position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 2,462 Twist Bioscience shares in Q2 2023, an estimated $36.9K.
  • Walleye Trading first reported a position in Twist Bioscience in Q4 2020 and held it in 7 quarters.
  • Walleye Trading's Twist Bioscience position peaked at $212K in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.